DLK1 Gene: Delta Like Non-Canonical Notch Ligand 1

A paternally expressed imprinted gene involved in development, adipogenesis, and tumorigenesis.

Gene Information Card

Symbol DLK1
Full Name Delta Like Non-Canonical Notch Ligand 1
Gene Type Protein coding
Chromosomal Location 14q32.2
NCBI Gene ID 8788 ncbi.nlm.nih.gov/gene/8788
Ensembl ID ENSG00000185559
UniProt ID P80370
OMIM ID 176290
HGNC ID 2907
Aliases FA1, PREF1, ZOG, pG2, Pref-1, DLK-1, Delta1

Description

DLK1 (Delta Like Non-Canonical Notch Ligand 1) is a paternally expressed imprinted gene located on chromosome 14q32.2. It encodes a transmembrane protein containing epidermal growth factor (EGF)-like repeats that functions as a non-canonical inhibitor of Notch signaling. DLK1 plays critical roles in adipogenesis, neuroendocrine differentiation, and skeletal development. It is highly expressed in fetal tissues and certain cancers, including hepatocellular carcinoma and neuroblastoma, where it is associated with poor prognosis.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Hepatocellular carcinoma Overexpression of DLK1 promotes tumor growth and inhibits apoptosis via Notch pathway modulation PMID: 23541953; COSMIC gene analysis
Neuroblastoma DLK1 is highly expressed in neuroblastoma cells and correlates with unfavorable histology and MYCN amplification PMID: 15604238; ClinVar
Central precocious puberty Mutations in DLK1 are associated with imprinted defects leading to early puberty PMID: 28566283; OMIM 176290
Adipogenesis disorders DLK1 inhibits adipocyte differentiation; altered expression linked to metabolic syndrome PMID: 10652251; UniProt

Expression Profile

Tissue Expression
Tissue nTPM level
Adrenal gland 45.2 High
Placenta 38.7 High
Pancreas 22.1 Medium
Liver 15.3 Medium
Brain 8.4 Low
Skeletal muscle 2.1 Not detected
Cell Line Expression
Cell Line nTPM Notes
HepG2 (liver cancer) 62.5 High expression; used as model for DLK1 function
SK-N-SH (neuroblastoma) 48.3 High expression; associated with MYCN amplification
MCF7 (breast cancer) 12.1 Moderate expression
HEK293 (embryonic kidney) 3.2 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.632C>T (p.Thr211Met) Missense Rare Unknown functional effect; reported in ClinVar
c.1A>G (p.Met1?) Start loss Very rare Likely loss of function; associated with central precocious puberty
c.1063_1064insA (p.Thr355Asnfs*12) Frameshift Rare Loss of function; truncation of C-terminal domain
Mutation functional classification

Loss of Function (LOF)

Frameshift and start-loss mutations that disrupt protein synthesis or truncate the functional domain are classified as loss-of-function.

Gain of Function (GOF)

No well-characterized gain-of-function mutations reported in DLK1.

Dominant Negative (DN)

Not established for DLK1; the gene is imprinted and monoallelically expressed, reducing dominant-negative potential.

Pathways

Notch signaling pathway (KEGG: hsa04330)
Adipogenesis (Reactome: R-HSA-381340)
Developmental biology (Reactome: R-HSA-1266738)

Protein Summary

The DLK1 protein (UniProt P80370) is a 383-amino-acid transmembrane glycoprotein with six EGF-like repeats in its extracellular domain. It is synthesized as a precursor that is cleaved to generate a soluble form (fetal antigen 1, FA1). DLK1 acts as a non-canonical ligand for Notch receptors, inhibiting Notch signaling and thereby regulating cell differentiation, particularly in adipogenesis and neuroendocrine tissues. The protein is highly expressed during fetal development and is re-expressed in various cancers.

Related Products

Product name Cat.No. Species Gene ID
DLK1 Knockout HEK293 Cell Line EDJ-KQ1971 Human 8788 Details Get a Quote
DLK1 Knockout HeLa Cell Line EDJ-KQ55005 Human 8788 Details Get a Quote
DLK1 Knockout A-549 Cell Line EDJ-KQ63489 Human 8788 Details Get a Quote
DLK1 Knockout HCT 116 Cell Line EDJ-KQ71958 Human 8788 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: